Pan-European Sarcoma Trials: Moving Forward
Author Information
Author(s): Dorothe Carrle, Tobias Dantonello, Stefan S. Bielack
Primary Institution: Klinikum Stuttgart, Olgahospital
Conclusion
The conference highlighted the challenges and strategies for conducting multinational sarcoma trials in Europe amidst regulatory pressures.
Supporting Evidence
- The conference aimed to provide an overview of active and planned multinational studies on sarcomas.
- Participants discussed the impact of EU regulations on clinical trials.
- Collaborative efforts were emphasized as essential for future research.
Takeaway
Researchers from many countries met to discuss how to keep studying and treating sarcoma despite new rules that make it harder to do so.
Methodology
The conference included presentations and discussions among over two hundred investigators from 19 countries about ongoing and planned sarcoma studies.
Limitations
The increased administrative and financial burdens from new regulations may hinder the initiation of new studies.
Participant Demographics
Over 200 investigators from 19 countries participated.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website